Dimitrios T. Farmakis MD, PhD, FESC, FHFA

Dimitrios Farmakis graduated from the Medical School of the National and Kapodistrian University of Athens and received his Doctoral Degree in hemoglobinopathy-associated heart disease from the same university in 2003. He specialized in Cardiology at Athens University Hospital “Attikon” and received his board certification in 2008. He was further trained in Cardio-Oncology at Bern University Hospital “Inselspital”, Bern, Switzerland, in Heart Failure at Zurich University Medical School, Zurich, Switzerland, and in Clinical Trials at Harvard Medical School, Boston, U.S.A., by which he was awarded a distinction.

Dr. Farmakis has worked at the National and Kapodistrian University of Athens Medical School as a scientific collaborator, academic scholar, consultant cardiologist or lecturer between 1996-1997 (First Dept. of Medicine, Athens University Hospital ”Laiko”) and 2008-2017 (Heart Failure Unit, Athens University Hospital ”Attikon”). Between 2012 and 2018, he was in charge of the Cardiac Clinic for Haemoglobinopathies at Athens University Hospital ”Laiko” and since 2015, of the Cardio-Oncology Clinic at Athens University Hospital “Attikon”. In 2017, Dr. Farmakis was elected an Assistant Professor of Pathophysiology at the European University of Cyprus Medical School and in 2018, an Associate Professor of Physiology at the University of Cyprus Medical School.

His research activity has focused on heart failure, hemoglobinopathies, cardiovascular pharmacology, and cardio-oncology. In total, Dr. Farmakis has published more than 220 articles, including 197 papers in international journals indexed in PubMed with a total impact factor of 1384, a total number of citations of 6655 (Google Scholar) and 5196 (Scopus), and an h index of 47 (Google Scholar) and 38 (Scopus). He has participated with abstracts in 218 international and national congresses. He has received grants for research protocols and programs and served as a primary investigator or steering committee member in research projects funded by the European Commission. He also sits on the editorial boards of three international medical journals and on several scientific or advisory committees, while he serves as a reviewer for many highly-rated journals.

Dr. Farmakis is the immediate past President of the Working Group for Cardiomyopathies and Basic Research of the Hellenic Society of Cardiology, a Fellow of the European Society of Cardiology (ESC), a member of the Heart Failure Association (HFA) of the ESC, a member of the Cardio-Oncology Committee of the HFA, an ex-officio a member of the Board of the ESC Cardio-Oncology Council and a former member of the Board and Treasurer of the Hellenic College of Cardiology. Finally, Dr. Farmakis has received awards from Greek and international organizations and scientific bodies, such as the National and Kapodistrian University of Athens Medical School (first award of excellence for the doctoral thesis), the University of Patras Medical School (distinguished young cardiologist award), the Harvard Medical School (distinction for the capstone project proposal), the American Heart Association and others.